首页> 外文期刊>Annals of surgical oncology >Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
【24h】

Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.

机译:根治性胃切除术和辅助化疗后晚期胃癌15年随访期间预后指标的变化:在一家韩国研究所进行的15年随访研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: We evaluated the long-term natural history of gastric cancer after radical gastrectomy and adjuvant chemotherapy through a 15-year follow-up study at a single institute. METHODS: Five hundred patients with advanced gastric adenocarcinoma who received radical gastrectomy and adjuvant chemotherapy were included in this long-term follow-up study. Patients were evaluated by imaging studies and upper gastrointestinal series or endoscopy every 6 months until the 10th year after surgery. Since then, the patients have been followed yearly in the same manner. RESULTS: The median follow-up period was 190.5 months. The recurrence rate in 5-year survivors was 10.8%. The dominant recurrence pattern was peritoneal carcinomatosis within 5 years and distant metastasis after 5 years post gastrectomy. Tumor stage was a clear-cut prognosticator within 5 years post gastrectomy, but was no longer informative in 5-10 years. At this period, only stage IV (IB-IIIB vs IVM0) was a significantly poor prognosticator. After 10 years, second primary cancer (seven cases) became as important an issue as recurrence of primary gastric cancer (six cases). CONCLUSIONS: In patients with gastric carcinoma treated with radical gastrectomy and adjuvant chemotherapy, late recurrence after 5 years post gastrectomy was not rare. Prognosticators were varied depending on the length of time after surgery. Tumor factors including stage were prognosticators within 5 years post gastrectomy, but tumor factors except stage IV had no prognostic value after 5 years. In the 5-10 years post gastrectomy, only stage IV (IB-IIIB vs IVM0) was a poor prognosticator. Also, after 10 years, there were no prognosticators.
机译:背景:我们通过在单个机构进行的15年随访研究评估了根治性胃切除术和辅助化疗后胃癌的长期自然病史。方法:这项长期随访研究包括了接受根治性胃切除术和辅助化疗的500例晚期胃腺癌患者。直到术后第10年,每6个月通过影像学检查,上消化道系列检查或内窥镜检查对患者进行评估。从那时起,每年都以同样的方式对患者进行随访。结果:中位随访期为190.5个月。 5年幸存者的复发率为10.8%。复发的主要方式是胃切除术后5年内发生腹膜癌和5年后远处转移。胃切除术后5年内,肿瘤分期是明确的预后指标,但5-10年后不再提供信息。在此期间,只有IV期(IB-IIIB与IVM0)是明显不良的预后者。 10年后,第二原发癌(七例)变得与原发性胃癌复发(六例)一样重要。结论:接受胃癌根治术和辅助化疗的胃癌患者,胃癌切除术后5年后复发​​的情况并不罕见。预后根据手术时间的长短而有所不同。胃切除术后5年内包括分期在内的肿瘤因素是预后因素,但IV期以外的肿瘤因素在5年后没有预后价值。在胃切除术后的5-10年中,只有IV期(IB-IIIB vs IVM0)预后不良。另外,十年后,没有预后者。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号